XML 65 R54.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity - Schedule of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Number of Options    
Outstanding, beginning of period (in shares) | shares 5,766,927  
Granted (in shares) | shares 2,710,163  
Exercised (in shares) | shares (573,791)  
Expired (in shares) | shares (63,175)  
Cancelled/Forfeited (in shares) | shares (93,243)  
Outstanding, end of period (in shares) | shares 7,746,881 5,766,927
Exercisable (in shares) | shares 4,365,983  
Unvested (in shares) | shares 3,380,898  
Weighted Average Exercise Price Per Share    
Outstanding, beginning of period (in dollars per share) | $ / shares $ 7.23  
Granted (in dollars per share) | $ / shares 15.62  
Exercised (in dollars per share) | $ / shares 7.59  
Expired (in dollars per share) | $ / shares 12.83  
Cancelled/Forfeited (in dollars per share) | $ / shares 10.33  
Outstanding, end of period (in dollars per share) | $ / shares 10.06 $ 7.23
Weighted Average Exercise Price, Exercisable (in dollars per share) | $ / shares 8.64  
Weighted Average Exercise Price, Unvested (in dollars per share) | $ / shares $ 11.88  
Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value    
Weighted Average Remaining Contractual Term (in years), Outstanding 8 years 7 years 6 months
Weighted Average Remaining Contractual Term (in years), Granted 9 years 4 months 24 days  
Weighted Average Remaining Contractual Term (in years), Exercisable 7 years 2 months 12 days  
Weighted Average Remaining Contractual Term (in years), Unvested 9 years  
Aggregate Intrinsic Value, Outstanding | $ $ 20,184 $ 28,796
Aggregate Intrinsic Value, Exercisable | $ 13,690  
Aggregate Intrinsic Value, Unvested | $ $ 6,494